These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 28092245)

  • 21. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease.
    Mayneris-Perxachs J; Guerendiain M; Castellote AI; Estruch R; Covas MI; Fitó M; Salas-Salvadó J; Martínez-González MA; Aros F; Lamuela-Raventós RM; López-Sabater MC;
    Clin Nutr; 2014 Feb; 33(1):90-7. PubMed ID: 23591154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of non-HDL cholesterol with the presence of metabolic syndrome in North Indian subjects with and without CAD.
    Garg PR; Kabita S; Sinha E; Kalla L; Kaur L; Saraswathy KN
    Ann Hum Biol; 2013 Jan; 40(1):111-5. PubMed ID: 23198906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a long-term lifestyle intervention program with Mediterranean diet and exercise for the management of patients with metabolic syndrome in a primary care setting.
    Gomez-Huelgas R; Jansen-Chaparro S; Baca-Osorio AJ; Mancera-Romero J; Tinahones FJ; Bernal-López MR
    Eur J Intern Med; 2015 Jun; 26(5):317-23. PubMed ID: 25907985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of variables associated with the metabolic syndrome from adolescence to adulthood: the Aerobics Center Longitudinal Study.
    Eisenmann JC; Welk GJ; Wickel EE; Blair SN;
    Am J Hum Biol; 2004; 16(6):690-6. PubMed ID: 15495227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordance between non-HDL cholesterol and LDL cholesterol levels in patients with diabetes without previous cardiovascular events.
    Idris I; Al-Ubaidi F
    Diabetes Metab; 2010 Sep; 36(4):299-304. PubMed ID: 20537932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lipid triad, or how to reduce residual cardiovascular risk?
    Girard-Mauduit S
    Ann Endocrinol (Paris); 2010 Mar; 71(2):89-94. PubMed ID: 20303470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.
    Leiter LA; Lundman P; da Silva PM; Drexel H; Jünger C; Gitt AK;
    Diabet Med; 2011 Nov; 28(11):1343-51. PubMed ID: 21679231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. American College of Endocrinology position statement on the insulin resistance syndrome.
    Einhorn D; Reaven GM; Cobin RH; Ford E; Ganda OP; Handelsman Y; Hellman R; Jellinger PS; Kendall D; Krauss RM; Neufeld ND; Petak SM; Rodbard HW; Seibel JA; Smith DA; Wilson PW
    Endocr Pract; 2003; 9(3):237-52. PubMed ID: 12924350
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
    Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
    Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial aggregation of components of the multiple metabolic syndrome in the Framingham Heart and Offspring Cohorts: Genetic Analysis Workshop Problem 1.
    Lee KE; Klein BE; Klein R
    BMC Genet; 2003 Dec; 4 Suppl 1(Suppl 1):S94. PubMed ID: 14975162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overweight patterns throughout childhood and cardiometabolic markers in early adolescence.
    Berentzen NE; van Rossem L; Gehring U; Koppelman GH; Postma DS; de Jongste JC; Smit HA; Wijga AH
    Int J Obes (Lond); 2016 Jan; 40(1):58-64. PubMed ID: 26395749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes and cardiovascular disease. Introduction.
    Chait A
    Atheroscler Suppl; 2006 Aug; 7(4):1-4. PubMed ID: 16822721
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.
    Deedwania PC; Shepherd J; Breazna A; DeMicco DA;
    Diabetes Obes Metab; 2016 Jan; 18(1):56-63. PubMed ID: 26434404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A health outcome assessment of the Cardio Metabolic Mission Health Program at Novartis.
    Mauceri E; Bienkowski C; Hanson KA; Doyle JJ; Jackson J; Bramer S
    J Occup Environ Med; 2011 Jun; 53(6):647-52. PubMed ID: 21654435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Total cholesterol, HDL-cholesterol and blood pressure in relation to life style: results of the first population screening of the Swiss MONIKA Project].
    Marti B; Dai S; Rickenbach M; Wietlisbach V; Bucher C; Barazzoni F; Gutzwiller F
    Schweiz Med Wochenschr; 1990 Dec; 120(51-52):1976-88. PubMed ID: 2274764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the International Diabetes Federation worldwide definition.
    Ezenwaka CE; Okoye O; Esonwune C; Onuoha P; Dioka C; Osuji C; Oguejiofor C; Meludu S
    Metab Syndr Relat Disord; 2014 Jun; 12(5):277-82. PubMed ID: 24601861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined influence of cardiorespiratory fitness and body mass index on cardiovascular disease risk factors among 8-18 year old youth: The Aerobics Center Longitudinal Study.
    Eisenmann JC; Welk GJ; Wickel EE; Blair SN
    Int J Pediatr Obes; 2007; 2(2):66-72. PubMed ID: 17763013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.